Cerus Corporation
CERS
#7883
Rank
C$0.57 B
Marketcap
C$2.84
Share price
-5.16%
Change (1 day)
26.69%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): C$1.67 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.22 Billion. In 2025 the company made an earning of -C$9.78 Million, an increase over its 2024 earnings that were of -C$16.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.67 M-117.13%
2025 -C$9.78 Million-41.58%
2024 -C$16.73 Million-58.95%
2023 -C$40.75 Million-20.74%
2022 -C$51.41 Million-25.7%
2021 -C$69.2 Million-11.99%
2020 -C$78.62 Million-14%
2019 -C$91.42 Million21.73%
2018 -C$75.1 Million-0.65%
2017 -C$75.59 Million-10.96%
2016 -C$84.9 Million4.24%
2015 -C$81.45 Million50.99%
2014 -C$53.94 Million-10.08%
2013 -C$59.99 Million184.13%
2012 -C$21.12 Million-7.91%
2011 -C$22.93 Million
2009 -C$32.38 Million-24.69%
2008 -C$43 Million-25.2%
2007 -C$57.48 Million330.54%
2006 -C$13.35 Million1.49%
2005 -C$13.16 Million-61.02%
2004 -C$33.75 Million
2002 -C$83.48 Million10.02%
2001 -C$75.88 Million34.25%
2000 -C$56.52 Million61.02%
1999 -C$35.1 Million-18.81%
1998 -C$43.24 Million93.08%
1997 -C$22.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.26 B 305,369.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$18.14 M 951.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.22 B 12,987.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$23.27 Million-1,448.57%๐Ÿ‡บ๐Ÿ‡ธ USA